Jane Street’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Jane Street’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-35,452	Closed	-$340K	–	11100
2024 Q4	$340K	Sell	35,452 -67,975	-66%	-$355K	﹤0.01%	7526
2024 Q3	$296K	Sell	103,427 -5,663	-5%	-$17.5K	﹤0.01%	8055
2024 Q2	$319K	Sell	109,090 -220,830	-67%	-$604K	﹤0.01%	7714
2024 Q1	$1.05M	Buy	329,920 +300,437	+1,019%	+$1M	﹤0.01%	5326
2023 Q4	$99.1K	Buy	+29,483	New	+$76K	﹤0.01%	8582
2023 Q2	–	Sell	-253,169	Closed	-$780K	–	9764
2023 Q1	$780K	Buy	253,169 +182,816	+260%	+$1.1M	﹤0.01%	5489
2022 Q4	$373K	Buy	+70,353	New	+$322K	﹤0.01%	6648
2021 Q3	–	Sell	-10,110	Closed	-$101K	–	10918
2021 Q2	$101K	Buy	+10,110	New	+$90.5K	﹤0.01%	9255

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's PSTX Position: Q1 2025 in Review

Jane Street sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 35,452 shares — an estimated $340K sold.

Jane Street first reported a position in PSTX in Q2 2021 and held it in 8 quarters. The position peaked at $1.05M in Q1 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Jane Street reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Jane Street sold 35,452 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $340K.
Jane Street first reported a position in Poseida Therapeutics, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Jane Street's Poseida Therapeutics, Inc. Common Stock position peaked at $1.05M in Q1 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.